Literature DB >> 3030332

The influence of enalapril or spironolactone on experimental cyclosporin nephrotoxicity.

F T McAuley, P H Whiting, A W Thomson, J G Simpson.   

Abstract

Adult Sprague-Dawley rats treated daily for 14 days with 50 mg/kg cyclosporin A (CsA) exhibited nephrotoxicity, characterized by reduced glomerular filtration rate, decreased urinary sodium and potassium flow, tubular enzymuria and proximal tubular structural damage. Elevations in plasma renin activity (PRA) were observed on day 4, but returned to normal within 7 days. Co-treatment of animals for the 14 day period with enalapril (8 mg/kg/day), a potent inhibitor of angiotensin converting enzyme (ACE), or spironolactone (25 mg/kg/day), the distal tubular antagonist of aldosterone, reduced the nephrotoxicity, although PRA remained elevated. Neither enalapril nor spironolactone affected circulating CsA levels. These data suggest that the action of aldosterone on the distal tubule may be important in the pathogenesis of CsA nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3030332     DOI: 10.1016/0006-2952(87)90721-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  6 in total

Review 1.  The pathophysiology of Sandimmune (cyclosporine) in man and animals.

Authors:  J Mason
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

2.  Vascular mechanisms of cyclosporin-induced hypertension in the rat.

Authors:  J B Roullet; H Xue; D A McCarron; S Holcomb; W M Bennett
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 3.  Adverse reactions and interactions of cyclosporin.

Authors:  J P Scott; T W Higenbottam
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr

Review 4.  Does Mineralocorticoid Receptor Antagonism Prevent Calcineurin Inhibitor-Induced Nephrotoxicity?

Authors:  Line Aas Mortensen; Claus Bistrup; Helle Charlotte Thiesson
Journal:  Front Med (Lausanne)       Date:  2017-11-24

5.  The mineralocorticoid receptor antagonist eplerenone reduces renal interstitial fibrosis after long-term cyclosporine treatment in rat: antagonizing cyclosporine nephrotoxicity.

Authors:  Finn Thomsen Nielsen; Boye L Jensen; Pernille B L Hansen; Niels Marcussen; Peter Bie
Journal:  BMC Nephrol       Date:  2013-02-20       Impact factor: 2.388

6.  The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity: a multicenter randomized, double-blind, clinical trial (the SPIREN trial).

Authors:  Line Aas Mortensen; Helle C Thiesson; Birgitte Tougaard; Martin Egfjord; Anne Sophie Lind Fischer; Claus Bistrup
Journal:  BMC Nephrol       Date:  2018-05-03       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.